Luyan Pharma Co., Ltd. (002788)
Market Closed
11 Aug, 06:57
XSHE XSHE Primary ¥
11. 70
+0.2
+1.7391%
¥
3.88B Market Cap
- P/E Ratio
1.4% Div Yield
34.61M Volume
- Eps
¥ 11.5
Previous Close Want to track 002788 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
002788 closed today higher at ¥11.7, an increase of 1.7391% from yesterday's close, completing a monthly increase of 17% or ¥1.7. Over the past 12 months, 002788 stock lost -38.7755%.
002788 pays dividends to its shareholders, with the most recent payment made on Jul 10, 2026. The next estimated payment will be in In 10 months on Jul 10, 2027 for a total of ¥0.35.
The last earnings report, released on May 07, 2025, exceeded the consensus estimates by 0.1836%. On average, the company has surpassed earnings expectations by 0.156%, based on the last three reports.
Luyan Pharma Co., Ltd. has completed 3 stock splits, with the recent split occurring on Sep 17, 2020.
The company's stock is traded on one exchange.
002788 Chart
People also search for
Luyan Pharma Co., Ltd. (002788) FAQ
What is the stock price today?
The current price is ¥11.70.
On which exchange is it traded?
Luyan Pharma Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 002788.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 1.4%.
What is its market cap?
As of today, the market cap is 3.88B.
Has Luyan Pharma Co., Ltd. ever had a stock split?
Luyan Pharma Co., Ltd. had 3 splits and the recent split was on Sep 17, 2020.
Luyan Pharma Co., Ltd. Profile
| Pharmaceuticals Industry | Healthcare Sector | Mr. Jinxiang Wu CEO | XSHE Exchange | CNE1000025W1 ISIN |
| China Country | 5,602 Employees | 10 Jul 2026 Last Dividend | 17 Sep 2020 Last Split | - IPO Date |
Overview
Luyan Pharma Co., Ltd. is a notable entity in the pharmaceutical industry within China, focusing on the advancement of human health through its diverse ventures. The company's core specialties include the research and development, production, and distribution of various health products. Initially established in 1992 and having undergone a rebranding from Luyan (Fujian) Pharma Co. Ltd. to its current name in June 2016, Luyan Pharma has cemented its footprint in the pharmaceutical sector. Its operations are strategically headquartered in Xiamen, China, from where it oversees a network of pharmaceutical distribution and retail direct stores across the region.
Products and Services
- Research and Development: Luyan Pharma Co.,Ltd. prides itself on its profound commitment to innovating in the health sector through its rigorous research and development activities. This facet of the company is dedicated to uncovering new pharmaceutical products and improving existing ones to better cater to the healthcare needs of the population.
- Production: At the heart of Luyan Pharma's operations lies its state-of-the-art production capabilities. The company is equipped with modern facilities to manufacture a wide range of human health products, adhering to stringent quality standards to ensure efficacy and safety.
- Sales: Luyan Pharma efficiently distributes its wide array of health products throughout China, leveraging a comprehensive network of pharmaceutical distribution channels. This ensures that its products are readily available to healthcare providers and patients alike.
- Retail Direct Stores: In addition to distribution, Luyan Pharma operates a series of retail direct stores. These outlets serve as key touchpoints for consumers, offering direct access to the company's health products and services, and thereby enhancing customer experience and satisfaction.
Contact Information
Address: No. 1004, Anling Road
Phone: 86 59 2812 8888
Website: https://www.luyan.com.cn
